NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) today announced final results from an analysis of all 2,246 adults enrolled in its Phase 2/3 EPIC-HR (Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients) trial of its…
The Chief of Clinical Science will serve as the AHA’s lead clinical science expert and provide valuable strategic input into the AHA’s interactions with technology organizations, industry, foundations, and governmental…
The American Medical Association seeks an Editor in Chief (“EIC”) of JAMA®, the Journal of the American Medical Association, and the JAMA Network. The EIC will lead one of the…
The Division of Cardiovascular Medicine at the Morehouse School of Medicine seeks subspecialty board certified Heart Failure Specialist for an academic appointment with the rank of Assistant or Associate Professor.…
Positive high-level results from the TACKLE Phase III COVID-19 treatment trial showed AstraZeneca’s AZD7442, a long-acting antibody (LAAB) combination, achieved a statistically significant reduction in severe COVID-19 or death compared…
